Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

Minga, Eva; Chamou, Dimitra; Kotaskova, Jana; Chatzikonstantinou, Thomas; Scarfo', Lydia; KARAKATSOULIS, GEORGIOS; Bosch, Francesc; IACOBONI, GLORIA

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Minga, Eva
dc.contributor.author	Chamou, Dimitra
dc.contributor.author	Kotaskova, Jana
dc.contributor.author	Chatzikonstantinou, Thomas
dc.contributor.author	Scarfo', Lydia
dc.contributor.author	KARAKATSOULIS, GEORGIOS
dc.contributor.author	Bosch, Francesc
dc.contributor.author	IACOBONI, GLORIA
dc.date.accessioned	2024-10-30T11:50:15Z
dc.date.available	2024-10-30T11:50:15Z
dc.date.issued	2024-09-17
dc.identifier.citation	Chatzikonstantinou T, Scarfò L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, et al. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. HemaSphere. 2024 Sep;8(9):e70004.
dc.identifier.issn	2572-9241
dc.identifier.uri	https://hdl.handle.net/11351/12156
dc.description	Therapeutic strategies; Chronic lymphocytic leukemia
dc.language.iso	eng
dc.publisher	Wiley
dc.relation.ispartofseries	HemaSphere;8(9)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Leucèmia limfocítica crònica - Tractament
dc.subject	Proteïnes quinases - Inhibidors - Ús terapèutic
dc.subject.mesh	Protein-Tyrosine Kinases
dc.subject.mesh	/antagonists & inhibitors
dc.subject.mesh	Leukemia, Lymphocytic, Chronic, B-Cell
dc.subject.mesh	/drug therapy
dc.title	Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1002/hem3.70004
dc.subject.decs	proteína-tirosina cinasas
dc.subject.decs	/antagonistas & inhibidores
dc.subject.decs	leucemia linfocítica crónica de células B
dc.subject.decs	/farmacoterapia
dc.relation.publishversion	https://doi.org/10.1002/hem3.70004
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Chatzikonstantinou T, Minga E, Karakatsoulis G, Chamou D] Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. [Scarfò L] Università Vita‐Salute San Raffaele, Milan, Italy. IRCCS Ospedale San Raffaele, Milan, Italy. [Kotaskova J] Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine‐Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. [Iacoboni G, Bosch F] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	39290716
dc.identifier.wos	001314048700001
dc.rights.accessrights	info:eu-repo/semantics/openAccess